EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

DNA-methylation and immunological response in medication overuse headache

Louise Ninett Carlsen iD, Christine Søholm Hansen, Lisette J A Kogelman iD, Thomas Mears Werge, Henrik Ullum, Jonas Bybjerg-Grauholm, Thomas Folkmann Hansen, Rigmor Højland Jensen

Cephalalgia · 2023-03 · 43 (3)

DOI: 10.1177/03331024221147482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cephalalgia, online erschienen am 14.02.2023. Verfasst von Louise Ninett Carlsen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Danish Headache Center, Rigshospitalet, Denmark. Hauptthemen laut MEDLINE: Headache Disorders, Secondary, Migraine Disorders. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate whether medication-overuse headache patients have differential DNA-methylation pattern.

Methods

We collected blood samples from 120 medication-overuse headache-patients, 57 controls (29 episodic migraine patients and 28 healthy controls) in a hypothesis-generating cross-sectional case-control pilot study; 100 of the medication-overuse headache-patients were followed for six months and samples were collected at two and six months for the longitudinal methylation analyses. Blood cell proportions of leucocytes (neutrophils, NK-cells, monocytes, CD8+ and CD4+ T-cells, and B-cells) and the neutrophile-lymphocyte ratio were estimated using methylation data as a measure for immunological analysis and a cell type-specific epigenome wide association study was conducted between medication-overuse headache-patients and controls, and longitudinally for reduction in headache days/month among medication-overuse headache-patients.

Results

We found a higher neutrophile-lymphocyte ratio in medication-overuse headache-patients compared to controls, indicating a higher immunological response in medication-overuse headache-patients (false discovery rate (adjusted p-value)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Headache Disorders, SecondaryMigraine DisordersHumansCross-Sectional StudiesPilot ProjectsHeadache

Stichwörter der Autor:innen

Biomarkerschronic headacheoveruse of analgesics

Autor:innen und Institutionen

  • Danish Headache Center, Rigshospitalet, Denmark.
  • Statens Serum Institute, Denmark.
  • Novo Nordisk Foundation Center for Protein Research, Copenhagen University, Denmark.

ORCID-Profile: Louise Ninett Carlsen, Lisette J A Kogelman

Zitieren

APA

Carlsen, L. N., Hansen, C. S., Kogelman, L. J. A., Werge, T. M., Ullum, H., Bybjerg-Grauholm, J., Hansen, T. F., & Jensen, R. H. (2023). DNA-methylation and immunological response in medication overuse headache. Cephalalgia, 43(3). https://doi.org/10.1177/03331024221147482

Vancouver

Carlsen LN, Hansen CS, Kogelman LJA, Werge TM, Ullum H, Bybjerg-Grauholm J, et al. DNA-methylation and immunological response in medication overuse headache. Cephalalgia. 2023;43(3). doi:10.1177/03331024221147482

BibTeX
@article{Carlsen2023,
  author = {Carlsen, Louise Ninett and Hansen, Christine Søholm and Kogelman, Lisette J A and Werge, Thomas Mears and Ullum, Henrik and Bybjerg-Grauholm, Jonas and Hansen, Thomas Folkmann and Jensen, Rigmor Højland},
  title = {DNA-methylation and immunological response in medication overuse headache},
  journal = {Cephalalgia},
  year = {2023},
  volume = {43},
  number = {3},
  doi = {10.1177/03331024221147482}
}
Kostenlos starten →